Efficacy of Energy Shots and Caffeine for Energy and Wakefulness Levels
Efficacy of "5-hour Energy"®, "5-Hour Energy Decaf"®, and Caffeine for Perceived Energy and Wakefulness
1 other identifier
interventional
48
1 country
1
Brief Summary
The line of "5-hour Energy"® products are available over-the-counter as energy supplements. The appeal of these products involves ease of use, low caloric value, and the absence of sugar to prevent a "crash" later in the day. The definitive efficacy and potency of the products is unknown due to the lack of evidence-based clinical reports. It is suspected that the efficacy related to these products is due to the caffeine content, which was reported as 138 mg per 2-ounce bottle in an online caffeine content chart. The purpose of this randomized, double-blind, placebo controlled, four way crossover study is to evaluate the efficacy of "5-hour Energy"®, "5-Hour Energy Decaf"®, caffeine, and placebo for perceived energy and wakefulness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 18, 2012
CompletedFirst Posted
Study publicly available on registry
December 24, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedJuly 9, 2013
July 1, 2013
4 months
December 18, 2012
July 6, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Subjective wakefulness levels based on assessment tool rankings
Subjects are provided with assessment tools to use for each product. The tool contains the Stanford Sleepiness Scale to assess for wakefulness levels. All appropriate options are listed, and subjects are required to circle one option at one, three, and five hours after taking the study product for the day.
At one, three, and five hours after taking the study product
Secondary Outcomes (1)
Number of patients experiencing adverse effects associated with study products
Within five hours after taking study product
Other Outcomes (1)
Study product consumed
Within the five hours after taking the study product
Study Arms (4)
Active ingredient
ACTIVE COMPARATORRegular "5-hour Energy"
Active ingredient-2
ACTIVE COMPARATOR"5-hour Energy Decaf"
Active ingredient-3
ACTIVE COMPARATORCompounded caffeine product 135 mg/2 ounces
Placebo
PLACEBO COMPARATORFlavored placebo
Interventions
Amount equivalent to the package commercially packaged and sold (1.93 fl. oz.)
Commercially available "5-Hour Energy Decaf" product in the amount that is packaged (1.93 fl. oz.)
Concentrated caffeine liquid has been used to compound a 135 mg/2 ounce caffeine product, which contains the same amount of caffeine as a regular "5-hour Energy"
Bottled water will be flavored and colored to serve as a placebo product for this trial.
Eligibility Criteria
You may not qualify if:
- Age less than 18 years
- Subjects who are pregnant or breast-feeding
- Diagnosis of any of the following disease states:
- Attention Deficit Hyperactive Disorder
- Anxiety
- Coronary Artery Disease
- Cardiac arrhythmias
- Cerebral vascular accident
- Narcolepsy
- Seizure disorders
- Uncontrolled hypertension
- Active therapy with stimulant medications - any medications containing amphetamine, atomoxetine, dextroamphetamine, diethylpropion, lisdexamfetamine, methylphenidate, phentermine, or modafinil
- Use of decongestants or other products containing phenylephrine or pseudoephedrine for more than 15 days within the past 30 days
- Subjects who work third shift or rotate to two or more different shifts for their job, not allowing them to have a regular sleep schedule
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Flower Hospital Family Medicine Residency
Sylvania, Ohio, 43560, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pharmacy Resident
Study Record Dates
First Submitted
December 18, 2012
First Posted
December 24, 2012
Study Start
December 1, 2012
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
July 9, 2013
Record last verified: 2013-07